Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
96 participants
OBSERVATIONAL
2025-04-01
2025-07-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pose Estimation and Inertial Measurement Unit Systems for Gait Analysis in Older Adults
NCT07119944
Validity and Reliability of The 3-Meter Backward Walk Test in Individuals With Lower Limb Amputation
NCT05095584
Evaluation of the Reproducibility of Jumping Mechanography
NCT01164670
Frailty and Assocciated Factors in Sarcopenia
NCT06931964
Applications of Ultrasound and Physical Parameters in Assessing Fall Risk in Patients With Knee Osteoarthritis
NCT06882928
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: This study proposes an upper extremity-based alternative, the Elbow Performance Test, and aims to evaluate its reliability in comparison to the commonly used 4-meter Gait Speed Test.
Method:This planned cross-sectional study will include two groups: older adults with sarcopenia and healthy young adults. All participants will undergo the 4-meter Gait Speed Test, the Short Physical Performance Battery (SPPB), the Timed Up and Go (TUG) test, and the Elbow Performance Test on two separate occasions, with a 7-10-day interval between sessions. In the Elbow Performance Test, a 1-kilogram sandbag will be attached to the distal forearm of the dominant arm, and participants will be instructed to perform 30 consecutive elbow flexion-extension movements. The total time required to complete the repetitions will be recorded. The reliability of the test will be evaluated using intraclass correlation coefficients (ICC).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
older adults with sarcopenia
physical performance tests
All participants underwent the 4-meter Gait Speed Test, the Short Physical Performance Battery (SPPB), the Timed Up and Go (TUG) test, and the Elbow Performance Test twice, with a 7-10-day interval between sessions. In the Elbow Performance Test, a 1-kilogram sandbag was fixed to the distal forearm of the dominant arm, and participants were asked to perform 30 consecutive elbow flexion-extension movements.
Group 2
healthy young adults
physical performance tests
All participants underwent the 4-meter Gait Speed Test, the Short Physical Performance Battery (SPPB), the Timed Up and Go (TUG) test, and the Elbow Performance Test twice, with a 7-10-day interval between sessions. In the Elbow Performance Test, a 1-kilogram sandbag was fixed to the distal forearm of the dominant arm, and participants were asked to perform 30 consecutive elbow flexion-extension movements.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
physical performance tests
All participants underwent the 4-meter Gait Speed Test, the Short Physical Performance Battery (SPPB), the Timed Up and Go (TUG) test, and the Elbow Performance Test twice, with a 7-10-day interval between sessions. In the Elbow Performance Test, a 1-kilogram sandbag was fixed to the distal forearm of the dominant arm, and participants were asked to perform 30 consecutive elbow flexion-extension movements.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\*Sarcopenia Group
* Male participants aged 60 years or older
* Diagnosed with sarcopenia according to EWGSOP2 criteria
\*Healthy Young Control Group
* Male participants aged 40 years or younger
* SARC-F screening test score \< 4
Exclusion Criteria
* Poor general condition due to acute medical problems
* Chronic decompensated cardiac, renal, or hepatic failure
* Presence of rheumatologic, psychiatric, or neurological disorders
* Use of performance-enhancing or fatigue-reducing medications
18 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eser Kalaoglu
M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
İlhan Karacan, Prof.
Role: STUDY_DIRECTOR
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bahat G, Tufan A, Tufan F, Kilic C, Akpinar TS, Kose M, Erten N, Karan MA, Cruz-Jentoft AJ. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr. 2016 Dec;35(6):1557-1563. doi: 10.1016/j.clnu.2016.02.002. Epub 2016 Feb 11.
Power GA, Dalton BH, Rice CL. Human neuromuscular structure and function in old age: A brief review. J Sport Health Sci. 2013 Dec;2(4):215-226. doi: 10.1016/j.jshs.2013.07.001.
Karacan I, Turker KS. Exploring neuronal mechanisms of osteosarcopenia in older adults. J Physiol. 2024 Aug 9. doi: 10.1113/JP285666. Online ahead of print.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IstPRMTRH-TYY1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.